Table 1. The association between PRSS8 expression and the clinicopathological characteristics.
| Clinicopathologic Variables | N | PRSS8 expression score | P value | ||
|---|---|---|---|---|---|
| 3 | 2 | 1 | |||
| Age | |||||
| Patient number (N=282) | 119 | 93 | 70 | ||
| Median age (years) | 59.0 | 56.5 | 62.0 | 0.822 | |
| Range | 27-82 | 36-86 | 33-85 | ||
| Gender | 0.088 | ||||
| Male | 143 | 69 (48%) | 40 (28%) | 34 (24%) | |
| Female | 139 | 50 (36%) | 53 (38%) | 36 (26%) | |
| Lymphatic metastasis | 0.157 | ||||
| Yes | 111 | 41 (37%) | 36 (32%) | 34 (31%) | |
| No | 171 | 78 (46%) | 57 (33%) | 36 (21%) | |
| Clinical stages | 0.0046 | ||||
| 1-2 | 149 | 70 (47%) | 50 (34%) | 29 (19%) | |
| 3-4 | 133 | 42 (32%) | 44 (33%) | 47 (35%) | |
| Differentiation | <0.00001 | ||||
| High | 135 | 74 (55%) | 37 (27%) | 24 (18%) | |
| Moderate | 112 | 40 (36%) | 45 (40%) | 27 (24%) | |
| Low | 35 | 5 (14%) | 12 (34%) | 18 (51%) | |
N, number of patients with colorectal cancers.